• Fatma Mohamed Awad MD, Radiology Department, Faculty of Medicine, Cairo University




Non-Mass Breast Lesions, DWI-MR Mammography, Apparent Diffusion Coefficient, DCIS

Abstract [English]

Background: Dynamic contrast-enhanced MRI is a sensitive tool for the diagnosis of breast cancer, however, its value is limited in cases of non-mass enhancement. Diffusion-weighted imaging (DWI) is promising in the diagnosis of non-mass breast lesions.

Purpose: The aim of this study is to determine the value of diffusion-weighted imaging in the evaluation of intermediate non-mass breast lesions, as an alternative to biopsy.

Materials and Methods: Thirty-three female patients between the ages of 38-56 years (mean age, 45 years) with non-mass lesions on MR mammography were included in this study. The lowest ADC values were obtained for the non-mass breast lesions. MR-guided core-needle biopsies were performed for 20 patients, while the other patients who refused biopsy, had yearly mammography and ultrasound every six months for two years. They also had at least one follow up MR mammography within the two years’ interval.

Results: This study included 33 non-mass breast lesions detected on MR mammography. The lesion siz¬es ranged from 0.2 to 1.4 cm. The morphological characteristics of the lesions and their signal intensity curves on dynamic MR Mammography were recorded. For differentiation of benign and malignant lesions, a threshold ADC value of 1.03×10–3   mm2/s was used. The ADC values for all the lesions ranged from 1.3 x 10–3 mm2/s to 2.6 x 10–3   mm2/s.

Conclusion: Diffusion-weighted imaging is effective in the evaluation of intermediate non-mass breast lesions on MR mammography and can be used as an alternative to biopsy.


Download data is not yet available.


Koh DM, Collins DJ. Diffusion-weighted MRI in the body: Applications and challenges in oncology. AJR Am J Roentgenol 2007; 188:1622–1635. DOI: https://doi.org/10.2214/AJR.06.1403

Englander SA, Uluğ AM, Brem R, et al. Diffusion imaging of human breast. NMR Biomed 1997; 10:348–352. DOI: https://doi.org/10.1002/(SICI)1099-1492(199710)10:7<348::AID-NBM487>3.0.CO;2-R

Kuroki Y, Nasu K, Kuroki S, et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: Analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004; 3:79–85. DOI: https://doi.org/10.2463/mrms.3.79

Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16:172–178. DOI: https://doi.org/10.1002/jmri.10140

Martincich L, Deantoni V, Bertotto I, et al. Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 2012; 22:1519-1528. DOI: https://doi.org/10.1007/s00330-012-2403-8

Ko ES, Han BK, Kim RB, et al. Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: Correlations with tumor-stroma ratio. Radiology 2014; 271:30-37. DOI: https://doi.org/10.1148/radiol.13131073

Diffusion-weighted breast imaging. Clinical implementation procedure. Wenkel E, Uder m, Janka R. Der Radiologe 2014; 54:224-232. DOI: https://doi.org/10.1007/s00117-013-2588-0

Ghai S, Muradali D, Bukhanov K, Kulkarni S. Nonenhancing breast malignancies on MRI: Sonographic and pathologic correlation. AJR Am J Roentgenol 2005; 185:481–487. DOI: https://doi.org/10.2214/ajr.185.2.01850481

Partridge SC, Mullins CD, Kurland BF, et al. Apparent Diffusion Coefficient values for discriminating benign and malignant breast MRI lesions: Effects of lesions type and size. AJR 2010; 194:1664-1673. DOI: https://doi.org/10.2214/AJR.09.3534

Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233:830–849. DOI: https://doi.org/10.1148/radiol.2333031484

Baltzer PAT, Benndrof M, Dietzel M, et al. False-positive findings at contrast-enhanced Breast MRI: A BIRADS Descriptor study. AJR 2010; 194:1658-1663. DOI: https://doi.org/10.2214/AJR.09.3486

Woodhams R, Ramadan S, Stanwell P, et al. Diffusion-weighted imaging of the breast: principles and clinical applica¬tions. Radiographics 2011; 31:1059–1084. DOI: https://doi.org/10.1148/rg.314105160

Blackledge MD, Leach MO, Collins DJ, Koh DM. Computed diffusion-weighted MR imaging may improve tumor detec¬tion. Radiology 2011; 261:573–581. DOI: https://doi.org/10.1148/radiol.11101919

Sinha S, Lucas-Quesada FA, Sinha U, et al. In vivo diffu¬sion-weighted MRI of the breast: poten¬tial for lesion characterization. J Magn Reson Imaging 2002; 15:693–704. DOI: https://doi.org/10.1002/jmri.10116

Bogner W, Gruber S, Pinker K, et al. Dif¬fusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 2009; 253:341–351.

Kitis O, Altay H, Calli C, et al. Minimum apparent diffu¬sion coefficients in the evaluation of brain tumors. Eur J Radiol 2005; 55:393–400. DOI: https://doi.org/10.1016/j.ejrad.2005.02.004

Hirano M, Satake H, Ishigaki S, et al. Diffusion-weight¬ed imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters. AJR Am J Roentgenol 2012; 198:717–722. DOI: https://doi.org/10.2214/AJR.11.7093

Şahin C, Arıbal E. The role of apparent diffusion coefficient values in the differential diagnosis of breast lesions in diffusion-weighted MRI. Diagn Interv Radiol 2013; 19:457–462.




How to Cite

Mohamed Awad, F. (2019). DIFFUSION-WEIGHTED IMAGING IN MR MAMMOGRAPHY AS AN ALTERNATIVE TO BIOPSY IN THE EVALUATION OF INTERMEDIATE NON-MASS BREAST LESIONS. International Journal of Research -GRANTHAALAYAH, 7(2), 171–179. https://doi.org/10.29121/granthaalayah.v7.i2.2019.1021